Could a simple skin zap spot melanoma sooner?

NCT ID NCT04705168

Completed Diagnosis Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a device called Nevisense, which measures the electrical properties of moles, can help doctors better assess suspicious moles during routine skin checks. Forty adults with many moles (at least 100) and several large moles took part. The goal is to improve early detection of melanoma, a serious skin cancer, in people at higher risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATYPICAL MOLE SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

melanocytic nevus melanoma, cutaneous malignant, susceptibility to, 2

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LARGE ACQUIRED NEVI MULTIPLE NEVI NEVUS SKIN LESION

Contacts and locations

Locations

Memorial Sloan Kettering Basking Ridge (Consent only)

Basking Ridge, New Jersey, 07920, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, 10065, United States
Memorial Sloan Kettering Westchester (Consent only)

Harrison, New York, 10604, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.